T. Nakano et al., INTERLEUKIN-6 AND ITS RELATIONSHIP TO CLINICAL-PARAMETERS IN PATIENTSWITH MALIGNANT PLEURAL MESOTHELIOMA, British Journal of Cancer, 77(6), 1998, pp. 907-912
The relationship between interleukin 6 (IL-6) levels and clinical para
meters was studied in 25 patients with malignant pleural mesothelioma.
The serum levels of IL-6, C-reactive protein, alpha(1)-acid glycoprot
ein and fibrinogen were significantly higher in mesothelioma than in l
ung adenocarcinoma with cytology-positive pleural effusion. Serum IL-6
levels correlated with the levels of the acute-phase proteins. We dem
onstrated a high incidence of thrombocytosis (48%) and a significant c
orrelation between platelet count and the serum IL-6 level. The level
of IL-6 in the pleural fluid of patients with mesothelioma was signifi
cantly higher than in the pleural fluid of patients with adenocarcinom
a, and was about 60-1400 times higher than in the serum. However, even
higher levels of IL-6 in the pleural fluid and of thrombocytosis were
found in patients with tuberculous pleurisy. These results indicate t
hat large amounts of IL-6 from the pleural fluid of patients with meso
thelioma leak into the systemic circulation and induce clinical inflam
matory reactions. These profiles are not specific to mesothelioma as s
imilar profiles are found in patients with tuberculous pleurisy. Howev
er, the detection of a markedly increased level of IL-6 in pleural flu
id argues against a diagnosis of adenocarcinoma.